Venable·IP / PATENT
Firm tracker maps pegfilgrastim patent claims challenged in litigation and IPRs
Venable's October 2026 spotlight inventories the Neulasta and biosimilar pegfilgrastim patent claims challenged in district court litigation and IPRs, counting the same patent's claims once per proceeding.
pegfilgrastimbiosimilarpost-grant-reviewiprclaim-challengepatent-litigation
Read the original firm alert → Thursday, October 15, 2026